No one test can confirm that someone has mild cognitive impairment (MCI). A diagnosis is made based on the information you provide and results of tests that can help clarify the diagnosis.

Many health care providers diagnose MCI based on criteria developed by a panel of international experts:

  • Problems with memory or another mental function. People with MCI may have problems with memory, planning, following instructions or making decisions. A provider may confirm these issues with a family member or a close friend.
  • Mental function that declines over time. This is revealed with a careful medical history. The change is confirmed by a family member or a close friend.
  • Daily activities aren't affected. Although symptoms may cause worry, people with MCI are still able to live their lives as usual.
  • Mental status testing shows mild level of impairment for age and education level. Health care providers often use a brief test such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may help determine the degree memory is impaired. The tests also may reveal the types of memory most affected and whether other mental skills also are impaired.
  • The diagnosis isn't dementia. The problems aren't severe enough to be diagnosed as Alzheimer's disease dementia or another type of dementia.

Neurological exam

As part of a physical exam, a health care provider may perform some basic tests that can reveal how well the brain and nervous system are working. These tests can help detect signs of Parkinson's disease, strokes, tumors or other medical conditions that can impair memory and physical function.

The neurological exam may test:

  • Reflexes
  • Eye movements
  • Walking and balance

Lab tests

Blood tests can help rule out physical problems that may affect memory. This can include not enough vitamin B-12 or thyroid hormone.

Brain imaging

An MRI or CT scan can check for a brain tumor, stroke or bleeding.

Mental status testing

Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions.

Longer forms of tests can provide details about how someone's mental function compares with others of a similar age and education. These tests also may help identify patterns of change that offer clues about the cause of symptoms.


Mild cognitive impairment is an active area of research. Clinical studies are being conducted to better understand the disorder and find treatments that may improve symptoms or prevent or delay dementia.

Alzheimer's drugs

The Alzheimer's medicine called cholinesterase inhibitors is sometimes given to people with MCI whose main symptom is memory loss. However, cholinesterase inhibitors aren't recommended for routine treatment of MCI. They haven't been found to affect progression to dementia, and they can cause side effects.

In 2021, the Food and Drug Administration (FDA) approved aducanumab (Aduhelm) for the treatment of some cases of Alzheimer's disease. The medicine was studied in people living with early Alzheimer's disease, including people with MCI due to Alzheimer's disease.

This medicine was approved in the United States because it removes amyloid plaques in the brain. However, the medicine has not been widely used because studies about its effectiveness at slowing cognitive decline were mixed and coverage is limited.

Another Alzheimer's medicine, lecanemab, has shown promise for people with mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease. It could become available in 2023. Not all people with MCI are expected to be eligible for the treatment, since only some have MCI due to Alzheimer's disease.

A phase 3 clinical trial found that the medicine slowed cognitive decline in people with early Alzheimer's disease by 27%. Lecanemab works by preventing amyloid plaques in the brain from clumping. This study was the largest so far to look at whether clearing clumps of amyloid plaques from the brain can slow the disease.

Lecanemab is under review by the FDA. Another study is looking at how effective the medicine may be for people at risk of Alzheimer's disease, including people who have a first-degree relative, such as a parent or sibling, with the disease.

Treating reversible causes of MCI: Stopping certain medicines

Certain medicines can cause side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. Discuss any side effects with your health care provider and never stop taking your medicine unless your provider tells you to do so. These medicines include:

  • Benzodiazepines, used to treat conditions such as anxiety, seizures and sleep disturbances
  • Anticholinergics, which affect chemicals in the nervous system to treat many different types of conditions
  • Antihistamines, often used to manage allergy symptoms
  • Opioids, often used to treat pain
  • Proton pump inhibitors, often used to treat reflux or gastroesophageal reflux disease (GERD)

Treating reversible causes of MCI: Other conditions

Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental function. Conditions that can affect memory include:

  • High blood pressure. People with MCI tend to be more likely to have problems with the blood vessels inside their brains. High blood pressure can worsen these problems and may cause memory loss. Your health care provider will monitor your blood pressure and recommend steps to lower it if it's too high.
  • Depression. When you're depressed, you often feel forgetful and mentally "foggy." Depression is common in people with MCI. Treating depression may help improve memory, while making it easier to cope with the changes in your life.
  • Sleep apnea. In this condition, your breathing stops and starts several times while you're asleep, interfering to get a good night's rest. Sleep apnea can make you feel very tired during the day, forgetful and not able to focus. Treatment can improve these symptoms and make you more alert during the day.

Clinical trials

Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.

Lifestyle and home remedies

Study results have been mixed about whether diet, exercise or other healthy lifestyle choices can prevent or reverse cognitive decline. Regardless, these healthy choices promote good overall health and may play a role in good cognitive health.

  • Regular physical exercise has known benefits for heart health. It also may help prevent or slow cognitive decline.
  • A diet low in fat and rich in fruits and vegetables is another heart-healthy choice that also may help protect brain health.
  • Omega-3 fatty acids also are good for the heart. Most research on omega-3s that shows a possible benefit for brain health looks at how much fish people eat.
  • Keeping your brain active may prevent cognitive decline. Studies have shown that playing games, playing an instrument, reading books and other activities may help preserve brain function.
  • Being social may make life more satisfying, help preserve mental function and slow mental decline.
  • Memory training and other cognitive training may help improve your function.

Alternative medicine

Some supplements — including vitamin E, ginkgo and others — have been suggested to help prevent or delay mild cognitive impairment. However, more research is needed in this area. Talk to your health care provider before taking supplements as they can interact with your current medicines.

Preparing for your appointment

You're likely to start by seeing your primary care provider. If your provider suspects that you have cognitive changes, you may be referred to a specialist. This specialist may be a neurologist, psychiatrist or neuropsychologist.

Because appointments can be brief and there's often a lot to talk about, it's good to be well prepared. Here are some ideas to help you get ready for your appointment and know what to expect from your provider.

What you can do

  • Be aware of any pre-appointment restrictions. When you make your appointment, ask if you need to fast for bloodwork or if you need to do anything else to prepare for diagnostic tests.
  • Write down all of your symptoms. Your health care provider will want to know details about what's causing your concern about your memory or mental function. Make notes about some of the most important examples of forgetfulness or other lapses you want to mention. Try to remember when you first started to suspect that something might be wrong. If you think your difficulties are getting worse, be ready to explain why.
  • Take along a family member or friend, if possible. Corroboration from a relative or trusted friend can play a key role in confirming that your memory loss is apparent to others. Having someone along also can help you remember all the information provided during your appointment.
  • Make a list of your other medical conditions. Your provider will want to know if you're currently being treated for diabetes, heart disease, past strokes or any other conditions.
  • Make a list of all your medicines. Your provider will want to know about any medicines you take. That includes prescription medicines, medicines available without a prescription, vitamins or supplements.

Questions to ask your doctor

Because time with your health care provider is limited, writing down a list of questions will help you make the most of your appointment. List your questions from most pressing to least important in case time runs out. For cognitive changes, some questions to ask your provider include:

  • Do I have a memory problem?
  • What's causing my symptoms?
  • What tests do I need?
  • Do I need to see a specialist? What will that cost? Will my insurance cover it?
  • Are treatments available?
  • Are there any clinical trials of experimental treatments I should consider?
  • Should I expect any long-term complications?
  • Will my new symptoms affect how I manage my other health conditions?
  • Do I need to follow any restrictions?
  • Is there a generic alternative to the medicine you're giving me?
  • Do you have any brochures or other printed material I can take home with me? What websites do you recommend?

In addition to the questions you've prepared ahead of time, don't hesitate to ask your health care provider to clarify anything you don't understand.

What to expect from your doctor

Your provider also is likely to have questions for you. Being ready to respond may free up time to focus on any points you want to talk about in-depth. Your provider may ask:

  • What kinds of memory issues are you having? When did they first appear?
  • Are they steadily getting worse, or are they sometimes better and sometimes worse?
  • Do you feel any sadder or more anxious than usual?
  • Have you noticed any changes in the way you react to people or events?
  • Have you noticed any changes in how well or how long you sleep? Do you snore?
  • Do you have more energy than usual, less than usual or about the same?
  • What medicines are you taking? Are you taking any vitamins or supplements?
  • Do you drink alcohol? How much?
  • What other medical conditions are you being treated for?
  • Have you noticed any trembling or trouble walking?
  • Are you having any trouble remembering your medical appointments or when to take your medicine?
  • Have you had your hearing and vision tested recently?
  • Did anyone else in your family ever have memory trouble? Was anyone ever diagnosed with Alzheimer's disease or dementia?

Mild cognitive impairment (MCI) care at Mayo Clinic

Jan. 18, 2023
  1. Knopman DS, et al. Alzheimer disease. Nature Reviews. Disease Primers. 2021; doi:10.1038/s41572-021-00269-y.
  2. Jankovic J, et al., eds. Alzheimer disease and other dementias. In: Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Sept. 21, 2022.
  3. Zhuang L, et al. Cognitive assessment tools for mild cognitive impairment screening. Journal of Neurology. 2021; doi:10.1007/s00415-019-09506-7.
  4. What is mild cognitive impairment? National Institute on Aging. https://www.nia.nih.gov/health/what-mild-cognitive-impairment. Accessed Sept. 21, 2022.
  5. Mild cognitive impairment (MCI). Alzheimer's Association. https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment. Accessed Sept. 21, 2022.
  6. Lewis JE, et al. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Journal of Clinical and Translational Research. 2021; doi:10.18053/jctres.07.202104.014.
  7. Kellerman RD, et al. Alzheimer's disease. In: Conn's Current Therapy 2022. Elsevier; 2022. https://www.clinicalkey.com. Accessed Sept. 21, 2022.
  8. Ferri FF. Mild cognitive impairment. In: Ferri's Clinical Advisor 2023. Elsevier; 2023. https://www.clinicalkey.com. Accessed Sept. 21, 2022.
  9. Petersen RC, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018; doi:10.1212/WNL.0000000000004826.
  10. Budson AE, et al. Subjective cognitive decline, mild cognitive impairment and dementia. In: Memory Loss, Alzheimer's Disease, and Dementia. 3rd ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Sept. 21, 2022.
  11. Cognitive impairment in older adults: Screening. U.S. Preventive Services Task Force recommendation statement. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening. Accessed Sept. 21, 2022.
  12. Levenson JL, ed. Dementia. In: The American Psychiatric Association Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry. 3rd ed. American Psychiatric Association Publishing; 2019. https://psychiatryonline.org. Accessed Sept. 21, 2022.
  13. Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020; doi:10.1016/S0140-6736(20)30367-6.
  14. Abdi Beshir S, et al. Aducanumab therapy to treat Alzheimer's disease: A narrative review. International Journal of Alzheimer's Disease. 2022; doi:10.1155/2022/9343514.
  15. Memory, forgetfulness and aging: What's normal and what's not? National Institute on Aging. https://www.nia.nih.gov/health/memory-forgetfulness-and-aging-whats-normal-and-whats-not. Accessed Sept. 26, 2022.
  16. Ami T. Allscripts EPSi. Mayo Clinic. April 21, 2022.
  17. Alzheimer's disease research centers. National Institute on Aging. https://www.nia.nih.gov/health/alzheimers-disease-research-centers#minnesota. Accessed Sept. 26, 2022.
  18. About the Alzheimer's Consortium. Arizona Alzheimer's Consortium. https://azalz.org/about/#institutes. Accessed Sept. 26, 2022.
  19. Aducanumab approved for treatment of Alzheimer's disease. Alzheimer's Association. https://www.alz.org/alzheimers-dementia/treatments/aducanumab. Accessed Sept. 28, 2022.
  20. Graff-Radford J (expert opinion). Mayo Clinic. Sept. 30, 2022.
  21. Shi M, et al. Impact of anti-amyloid-β monoclonal antibodies on the pathology and clinical profile of Alzheimer's disease: A focus on aducanumab and lecanemab. Frontiers in Aging and Neuroscience. 2022; doi:10.3389/fnagi.2022.870517.
  22. Cummings J, et al. Alzheimer's disease drug development pipeline: 2022. Alzheimer's and Dementia. 2022; doi:10.1002/trc2.12295.